Terao S - Search Results

1

Zoledronate stimulates gamma delta T cells in prostate cancer patients.

Naoe M, Ogawa Y, Takeshita K, Morita J, Shichijo T, Fuji K, Fukagai T, Iwamoto S, Terao S. Naoe M, et al. Among authors: terao s. Oncol Res. 2010;18(10):493-501. doi: 10.3727/096504010x12671222663638. Oncol Res. 2010. PMID: 20681408

2

Expression of the fluoropyrimidine-metabolizing enzymes in bladder cancers as measured by the Danenberg tumor profile.

Naoe M, Ogawa Y, Morita J, Shichijo T, Fuji K, Takeshita K, Kushima M, Terao S, Yamochi T, Ota H. Naoe M, et al. Among authors: terao s. Oncol Res. 2009;18(4):153-62. doi: 10.3727/096504009790217371. Oncol Res. 2009. PMID: 20112501

3

Enhancement of IL-2-induced cytotoxicity by interferon-alpha in renal cell carcinoma.

Naoe M, Ogawa Y, Hasebe Y, Morita J, Shichijo T, Igarashi A, Fuji K, Iwamoto S, Suzuki T, Terao S. Naoe M, et al. Among authors: terao s. Oncol Res. 2011;19(10-11):479-86. doi: 10.3727/096504012x13285365944373. Oncol Res. 2011. PMID: 22715591

4

The antitumour effect of {gamma}{delta} T-cells is enhanced by valproic acid-induced up-regulation of NKG2D ligands.

Suzuki T, Terao S, Acharya B, Naoe M, Yamamoto S, Okamura H, Gotoh A. Suzuki T, et al. Among authors: terao s. Anticancer Res. 2010 Nov;30(11):4509-13. Anticancer Res. 2010. PMID: 21115900

5

A pilot study of quality of life of patients with hormone-refractory prostate cancer after gene therapy.

Terao S, Shirakawa T, Acharya B, Miyata M, Hinata N, Tanaka K, Takenaka A, Hara I, Naoe M, Fuji K, Okegawa T, Higashihara E, Kamidono S, Fujisawa M, Gotoh A. Terao S, et al. Anticancer Res. 2009 May;29(5):1533-7. Anticancer Res. 2009. PMID: 19443362 Free article.

6

Improved gene transfer into renal carcinoma cells using adenovirus vector containing RGD motif.

Terao S, Acharya B, Suzuki T, Aoi T, Naoe M, Hamada K, Mizuguchi H, Gotoh A. Terao S, et al. Anticancer Res. 2009 Aug;29(8):2997-3001. Anticancer Res. 2009. PMID: 19661307 Free article.

7

Improving gene transfer in human renal carcinoma cells: Utilization of adenovirus vectors containing chimeric type 5 and type 35 fiber proteins.

Acharya B, Terao S, Suzuki T, Naoe M, Hamada K, Mizuguchi H, Gotoh A. Acharya B, et al. Among authors: terao s. Exp Ther Med. 2010 May;1(3):537-540. doi: 10.3892/etm_00000085. Epub 2010 May 1. Exp Ther Med. 2010. PMID: 22993573 Free PMC article.

8

Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer.

Shirakawa T, Terao S, Hinata N, Tanaka K, Takenaka A, Hara I, Sugimura K, Matsuo M, Hamada K, Fuji K, Okegawa T, Higashihara E, Gardner TA, Kao C, Chung LW, Kamidono S, Fujisawa M, Gotoh A. Shirakawa T, et al. Among authors: terao s. Hum Gene Ther. 2007 Dec;18(12):1225-32. doi: 10.1089/hum.2007.074. Hum Gene Ther. 2007. PMID: 18021019 Clinical Trial.

9

Recombinant interleukin-2 enhanced the antitumor effect of ADV/RSV-HSV-tk/ACV therapy in a murine bladder cancer model.

Terao S, Shirakawa T, Goda K, Kamidono S, Fujisawa M, Gotoh A. Terao S, et al. Anticancer Res. 2005 Jul-Aug;25(4):2757-60. Anticancer Res. 2005. PMID: 16080522 Free article.

10

Improved gene transfer into bladder cancer cells using adenovirus vector containing RGD motif.

Hiwasa K, Nagaya H, Terao S, Acharya B, Hamada K, Mizuguchi H, Gotoh A. Hiwasa K, et al. Among authors: terao s. Anticancer Res. 2012 Aug;32(8):3137-40. Anticancer Res. 2012. PMID: 22843884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters